Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2022 02:00 ET | Source: Xinvento BV

Dutch biotech Xinvento raises seed round to develop a treatment for the rare disease Congenital Hyperinsulinism

AMSTERDAM, April 21, 2022 (GLOBE NEWSWIRE) -- Xinvento, a biotech company aiming to improve the lives of those with Congenital Hyperinsulinism, announces today the completion of a seed funding...